2015 May 02
Molecular Mutations in MDS
Gail J. Roboz, M.D., director of Weill's Leukemia Program, discusses molecular mutations in myelodysplastic syndromes (MDS). Read more
2015 Apr 30
Lis elected to American Academy of Arts and Sciences
Meyer Cancer Center member John Lis, the Barbara McClintock Professor of Molecular Biology and Genetics based in Ithaca, was among three Cornell faculty members recently elected to the American Academy of Arts and Sciences. Read more
2015 Apr 29
Uncovering new functions of a gene implicated in cancer growth opens new therapeutic possibilities
Research by David Lyden into the immune suppression function of the Inhibitor of Differentiation 1 gene may lead to new therapies for melanoma and other advanced-stage cancers. Read more
2015 Apr 29
Esophageal cancer: What happens after 5 years?
Esophageal cancer patients who survived five years after surgery were likely to survive longer despite recurrence risk, according to a new study by Brendon Stiles, M.D. Read more
2015 Apr 28
Precision Medicine: Working Toward Custom-Fitted Cures
Mark Rubin speaks to U.S. News and World Reports about the future of precision medicine Read more
2015 Apr 27
The brain tumor is benign, but threats remain
Susan Pannullo talks to the New York Times about the importance of detecting brain tumors when they are small. Read more
2015 Apr 23
Cornell "cosmeceutical" cancer prevention cream inspires start-up
CUL4A Ubiquitin Ligase inhibitors technology created by pathology professor Pengbo Zhou is making its way to market. Read more
2015 Apr 23
Tumor cells prefer easy way out
Cynthia Reinhart-King study illuminates the mechanics of tumor cell migration. Read more
2015 Apr 23
Clinical experience in gastric cancer and present positioning of anti-angiogenesis drugs
Manish Shah, M.D., speaks about the use of anti-angiogenesis drugs in gastric cancer at an event in Milan, Italy. Read more
2015 Apr 22
Another kudos for Cantley
Meyer director Lewis Cantley has been named the recipient of the 3rd annual Ross Prize in Molecular Medicine. Read more
2015 Apr 21
New tool predicts drug targets and IDs new anticancer compounds
A new computational tool mines millions of data points to shed light on the targets and actions of certain molecules Read more
2015 Apr 20
Changes in cancer epigenome implicated in chemotherapy resistance and lymphoma relapse
A study in Nature Communications by Olivier Elemento and colleagues suggests that global changes in cancer cells' epigenome may be a powerful force in determining disease progression Read more
2015 Apr 20
How patients can benefit from clinical trials
John Leonard talks about the benefit of participating in clinical trials at reputable research institutions. Read more
2015 Apr 19
New study shows aspirin use can cut the risk of some kinds of cancer
Heather Yeo speaks to CBS Evening News about new aspirin study. Read more
2015 Apr 16
Immunotherapy research in pancreatic cancer given $1m boost
Douglas Fearon has received a grant to support his research into eliminating T cell barriers in pancreatic cancer patients. Read more
2015 Apr 15
New genomic research amends earlier triple negative breast cancer finding
A paper in Nature from Mark Rubin, Sandra Shin and Juan Miguel Mosquera underscores the importance of independent study validation and careful assay development. Read more
2015 Apr 15
Big Data Key to Precision Medicine's Success
Mark A. Rubin, director of the Institute for Precision Medicine, writes in Nature about the practicalities of realizing the potential of precision medicine. Read more
2015 Apr 14
Researchers Sequence Genome of Anaplastic Large Cell Lymphoma
A team of researchers led by Giorgio Inghirami has discovered a pair of genetic mutations that drive tumor growth in patients who have a deadly subtype of T-cell lymphoma. Read more
2015 Apr 13
Researcher's resolve leads to breakthrough drug
Selina Chen-Kiang's investigations into the cell cycle helped lead to the successful launch of CDK4/6 inhibitor palbociclib (IBRANCE). Read more
2015 Apr 12
Can cancer be stopped?
Harold Varmus, M.D., pens a guest piece in the New York Daily News about the remarkable progress made in cancer research and the daunting road ahead. Read more
